Profund Advisors’s Hemab Therapeutics COAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$246K Buy
+7,961
New +$349K 0.01% 870

Other funds holding COAG

Profund Advisors's COAG Position: Q3 2026 in Review

Profund Advisors opened a new position in Hemab Therapeutics (COAG) in Q3 2026: 7,961 shares worth $246K. The stake represents 0.01% of the portfolio and ranks #870 among its holdings.

87 funds tracked by Wall St. Rank hold COAG as of Q3 2026.

  • Profund Advisors held 7,961 shares of Hemab Therapeutics worth $246K as of Q3 2026.
  • Hemab Therapeutics was a new Profund Advisors position in Q3 2026.
  • Hemab Therapeutics made up 0.01% of Profund Advisors's portfolio in Q3 2026, its #870 holding.
  • 87 funds tracked by Wall St. Rank held Hemab Therapeutics as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.